Cogent Biosciences, Inc.
COGT
Rang în acțiuni
#3382
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted... Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.
Preț acțiune
$29.64
Ultima sincronizare: 2026-10-16
Capitalizare de piață
$5.14B
Schimbare (1 zi)
0.44%
Schimbare (1 an)
80.83%
Țară
US
Tranzacționează Cogent Biosciences, Inc. (COGT)
Categorie
Healthcare
EPS pentru Cogent Biosciences, Inc. (COGT)
EPS la data de June 2026 TTM: $-2.31
Conform celor mai recente rapoarte financiare și prețului acțiunilor Cogent Biosciences, Inc., EPS-ul actual al companiei (TTM) este $-2.31. La sfârșitul anului 2023, compania avea un EPS de $-2.42 o creștere față de EPS-ului din 2022, care a fost de $-2.26.
Istoricul EPS pentru Cogent Biosciences, Inc. din 2015 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $-2.31 | -6.10% |
| 2024 | $-2.46 | 1.65% |
| 2023 | $-2.42 | 7.08% |
| 2022 | $-2.26 | 22.16% |
| 2021 | $-1.85 | -69.17% |
| 2020 | $-6.00 | 51.13% |
| 2019 | $-3.97 | -28.47% |
| 2018 | $-5.55 | 60.87% |
| 2017 | $-3.45 | 11.29% |
| 2016 | $-3.10 | 174.34% |
| 2015 | $-1.13 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $17.32 | -849.78% |
US
|
|
| $-7.98 | 245.45% |
US
|
|
| $-5.29 | 129.00% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -1,300.87% |
NL
|
